These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29946961)

  • 21. Opioid dependence and NMDA receptors.
    Glass MJ
    ILAR J; 2011; 52(3):342-51. PubMed ID: 23382148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic Pain, Chronic Opioid Addiction: a Complex Nexus.
    Salsitz EA
    J Med Toxicol; 2016 Mar; 12(1):54-7. PubMed ID: 26602212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug addiction. Part II. Neurobiology of addiction.
    Vetulani J
    Pol J Pharmacol; 2001; 53(4):303-17. PubMed ID: 11990077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic noncancer pain: do different measures identify the same patients?
    Campbell G; Bruno R; Lintzeris N; Cohen M; Nielsen S; Hall W; Larance B; Mattick RP; Blyth F; Farrell M; Degenhardt L
    Pain; 2016 Jul; 157(7):1489-1498. PubMed ID: 26963848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Science of Addiction Through the Lens of Opioid Treatment for Chronic Noncancer Pain.
    Umberger W; Gaddis L
    Pain Manag Nurs; 2020 Feb; 21(1):57-64. PubMed ID: 31606310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addiction-related interactions of pregabalin with morphine in mice and humans: reinforcing and inhibiting effects.
    Vashchinkina E; Piippo O; Vekovischeva O; Krupitsky E; Ilyuk R; Neznanov N; Kazankov K; Zaplatkin I; Korpi ER
    Addict Biol; 2018 May; 23(3):945-958. PubMed ID: 28741741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioid tolerance and dependence: an inevitable consequence of chronic treatment?
    Adriaensen H; Vissers K; Noorduin H; Meert T
    Acta Anaesthesiol Belg; 2003; 54(1):37-47. PubMed ID: 12703345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine gene variants in opioid addiction: comparison of dependent patients, nondependent users and healthy controls.
    Randesi M; van den Brink W; Levran O; Yuferov V; Blanken P; van Ree JM; Ott J; Kreek MJ
    Pharmacogenomics; 2018 Jan; 19(2):95-104. PubMed ID: 29210332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid therapy in chronic pain.
    Ballantyne JC
    Phys Med Rehabil Clin N Am; 2015 May; 26(2):201-18. PubMed ID: 25952061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T394A Mutation at the μ Opioid Receptor Blocks Opioid Tolerance and Increases Vulnerability to Heroin Self-Administration in Mice.
    Wang XF; Barbier E; Chiu YT; He Y; Zhan J; Bi GH; Zhang HY; Feng B; Liu-Chen LY; Wang JB; Xi ZX
    J Neurosci; 2016 Oct; 36(40):10392-10403. PubMed ID: 27707973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergency Department Prescription Opioids as an Initial Exposure Preceding Addiction.
    Butler MM; Ancona RM; Beauchamp GA; Yamin CK; Winstanley EL; Hart KW; Ruffner AH; Ryan SW; Ryan RJ; Lindsell CJ; Lyons MS
    Ann Emerg Med; 2016 Aug; 68(2):202-8. PubMed ID: 26875061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphocyte opioid receptors as innovative biomarkers of osteoarthritic pain, for the assessment and risk management of opioid tailored therapy, before hip surgery, to prevent chronic pain and opioid tolerance/addiction development: OpMarkArt (Opioids-Markers-Arthroprosthesis) study protocol for a randomized controlled trial.
    Malafoglia V; Celi M; Muscoli C; Ilari S; Lauro F; Giancotti LA; Morabito C; Feola M; Tarantino U; Raffaeli W
    Trials; 2017 Dec; 18(1):605. PubMed ID: 29258584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of Gabapentin Overuse With or Without Concomitant Opioids in a Commercially Insured U.S. Population.
    Peckham AM; Evoy KE; Covvey JR; Ochs L; Fairman KA; Sclar DA
    Pharmacotherapy; 2018 Apr; 38(4):436-443. PubMed ID: 29484686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Genetic polymorphisms commonly influencing efficacy of diverse addictive substances].
    Nishizawa D; Ikeda K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2014 Apr; 49(2):83-91. PubMed ID: 24946391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A ghrelin receptor (GHS-R1A) antagonist attenuates the rewarding properties of morphine and increases opioid peptide levels in reward areas in mice.
    Engel JA; Nylander I; Jerlhag E
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2364-71. PubMed ID: 26508707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?
    Candiotti KA; Gitlin MC
    Curr Med Res Opin; 2010 Jul; 26(7):1677-84. PubMed ID: 20465361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of a novel site of opioid action at the innate immune pattern-recognition receptor TLR4 and its role in addiction.
    Jacobsen JH; Watkins LR; Hutchinson MR
    Int Rev Neurobiol; 2014; 118():129-63. PubMed ID: 25175864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The failing cascade: Comorbid post traumatic stress- and opioid use disorders.
    Elman I; Borsook D
    Neurosci Biobehav Rev; 2019 Aug; 103():374-383. PubMed ID: 31063739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain.
    Edlund MJ; Steffick D; Hudson T; Harris KM; Sullivan M
    Pain; 2007 Jun; 129(3):355-362. PubMed ID: 17449178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral and transcriptional patterns of protracted opioid self-administration in mice.
    Skupio U; Sikora M; Korostynski M; Wawrzczak-Bargiela A; Piechota M; Ficek J; Przewlocki R
    Addict Biol; 2017 Nov; 22(6):1802-1816. PubMed ID: 27578564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.